Frequently Asked Questions

Private Label Stock is built on existing, market-tested formulas, which typically allows for a shorter path to launch and a lower entry volume. It is well-suited for brands looking to move efficiently without a bespoke development phase. Custom OEM/ODM involves developing a proprietary formula tailored to your brand's specific requirements. This path requires a dedicated R&D and stability-testing phase, and the timeline and MOQ will vary depending on the complexity of the formulation and packaging chosen.

MOQs are indicative and will be confirmed during your project consultation, as they depend on the specific product category, formula complexity, and packaging selection.

• Private Label Stock Products: MOQ typically starts in the range of 2,000-6,000 units per SKU for standard configurations.
• Custom OEM/ODM Projects: MOQ generally starts from 6,000 units per SKU, though this may be higher for certain formulation or packaging types.

Note: Final MOQs are project-dependent and will be outlined in your formal quotation.

Lead times are estimates and will be confirmed at the project scoping stage. Key variables include packaging component availability, order volume, and the scope of any required testing.

• Private Label Stock: Production typically begins after final artwork and packaging approval. Indicative lead time is 3-6 weeks, subject to component lead times and order size.
• Custom OEM/ODM: From formula brief to delivery, the process generally spans 10-16 weeks or more, encompassing R&D iterations, stability and safety assessments, and production scheduling. Projects with complex formulations or custom packaging components may require additional time.

A detailed project timeline will be provided once your requirements have been reviewed.

For Custom OEM/ODM Projects, intellectual property terms -- including formula ownership -- are defined in the project agreement. Our standard approach is to assign the proprietary formula to the client brand upon project completion and full settlement. We are prepared to sign a Non-Disclosure Agreement (NDA) at the outset of any discussion to protect your project details. Specific IP arrangements will be outlined clearly in the contract prior to development commencing.

While the formula is pre-existing, there is meaningful flexibility in how the product is presented to market. Clients can typically select from available packaging formats (bottles, jars, tubes) and apply their own brand artwork and labeling. The degree of customization -- including component options and decoration methods -- depends on the specific product and order volume. Our team will advise on what is feasible within your project scope and help ensure that any packaging choices remain compatible with the formula and relevant labeling requirements for your target market.

We provide technical and documentary support to assist clients in meeting the regulatory requirements of their target markets. The scope of support available will depend on the product type, destination market, and service pathway chosen. Typical documentation we can assist with includes:

• Product dossier documents such as Certificate of Analysis (COA), Safety Data Sheet (SDS/MSDS), and stability study reports.
• Technical input for Product Information File (PIF) preparation, relevant for EU and UK market entry.
• Guidance on the CPNP notification process (EU) and SCPN registration (UK), noting that formal submission is the responsibility of the EU/UK Responsible Person.
• Background information to support FDA cosmetic registration for the US market.

Regulatory requirements vary by market and product category. We recommend clients work with a qualified local Responsible Person or regulatory consultant for formal submissions and compliance sign-off.

The most effective starting point is to submit a consultation request. To help us direct your enquiry appropriately, please indicate whether you are exploring a Private Label Stock or a Custom OEM/ODM solution, along with any initial details about your product category, target market, and expected volumes. A member of our team will follow up to schedule a discovery call and discuss next steps.

Our manufacturing network is comprised of facilities that operate under GMP (Good Manufacturing Practice) frameworks, which form the baseline quality standard across our partner factories. Depending on the specific facility assigned to your project, relevant certifications may include:

• ISO 22716 -- Cosmetics Good Manufacturing Practices
• GMPC -- Good Manufacturing Practice for Cosmetics
• FDA Facility Registration -- For products intended for the US market
• EU-aligned production standards -- Supporting European market documentation requirements

The certifications held by a given facility may vary. We will confirm the applicable certifications for your specific project during the scoping process and can provide supporting documentation upon request.

Sampling is a standard part of the qualification process for both service pathways, and we encourage clients to evaluate products thoroughly before committing to production volumes.

• Private Label Stock: Reference samples in standard packaging can typically be arranged to support your internal evaluation.
• Custom OEM/ODM: Formula samples are provided at defined stages of the R&D process, followed by pre-production samples incorporating your selected packaging once the formulation is approved.

Sample arrangements -- including quantities, associated costs, and international shipping -- are discussed and agreed during the consultation stage. Sample fees and applicable shipping charges will be outlined in advance. Whether sample costs are applied toward a subsequent production order is subject to the terms agreed for your specific project.

We work with international B2B clients across a range of markets. Our primary areas of focus include:

• European Union -- We can assist with documentation relevant to CPNP notification and EU cosmetics regulation requirements.
• United Kingdom -- Support available for SCPN-related documentation and UK market entry.
• United States -- Technical documentation to support FDA cosmetic registration processes.
• Australia & New Zealand -- Guidance available for clients navigating TGA and relevant local requirements.
• Southeast Asia -- Familiarity with ASEAN Cosmetic Directive frameworks and regional market entry considerations.
• Middle East & Africa -- Support assessed on a market-by-market basis depending on destination country requirements.

Regulatory requirements differ significantly by market, product category, and formulation. We provide technical documentation to support your market entry process, but clients are responsible for ensuring compliance with local regulations and for engaging qualified in-market representatives where required. Please share your target markets during consultation so we can advise on what documentation and support is available for your specific situation.